MA41812A - Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc - Google Patents
Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhcInfo
- Publication number
- MA41812A MA41812A MA041812A MA41812A MA41812A MA 41812 A MA41812 A MA 41812A MA 041812 A MA041812 A MA 041812A MA 41812 A MA41812 A MA 41812A MA 41812 A MA41812 A MA 41812A
- Authority
- MA
- Morocco
- Prior art keywords
- intermediaries
- hcv
- preparation
- methods
- protease inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/61—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15161431 | 2015-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA41812A true MA41812A (fr) | 2018-01-30 |
Family
ID=52737010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA041812A MA41812A (fr) | 2015-03-27 | 2016-03-24 | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc |
Country Status (15)
Country | Link |
---|---|
US (1) | US20180093943A1 (fr) |
EP (1) | EP3274324A1 (fr) |
JP (1) | JP2018517661A (fr) |
KR (1) | KR20170131449A (fr) |
CN (1) | CN107429270A (fr) |
AU (1) | AU2016241924A1 (fr) |
BR (1) | BR112017019898A2 (fr) |
CA (1) | CA2976175A1 (fr) |
EA (1) | EA201792114A1 (fr) |
HK (1) | HK1247246A1 (fr) |
IL (1) | IL253899A0 (fr) |
MA (1) | MA41812A (fr) |
MX (1) | MX2017012348A (fr) |
SG (1) | SG11201707594SA (fr) |
WO (1) | WO2016157058A1 (fr) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
JO2768B1 (en) * | 2005-07-29 | 2014-03-15 | تيبوتيك فارماسيوتيكالز ليمتد | Large cyclic inhibitors of hepatitis C virus |
JP5563830B2 (ja) | 2007-02-01 | 2014-07-30 | ヤンセン・アールアンドデイ・アイルランド | Hcvの大員環状プロテアーゼ阻害剤の製造のための方法及び中間体 |
MX2010011306A (es) | 2008-04-15 | 2010-11-09 | Intermune Inc | Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c. |
DK2382198T3 (da) | 2008-12-23 | 2013-09-30 | Janssen Pharmaceuticals Inc | Fremgangsmåder og mellemprodukter til fremstilling af en makrocyklisk inhibitor af hcv-protease |
BR112012023296B1 (pt) | 2010-03-16 | 2018-07-03 | Janssen Pharmaceuticals, Inc. | Processos para a preparação de ácido [(1r,2r)-4- oxo-1,2-ciclopentanodicarboxílico, lactona bicíclica e derivado de ciclopentano, bem como compostos intermediários para a preparação de um inibidor macrocíclico de protease de hcv |
CA2845321A1 (fr) * | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Traitements combines contre l'hepatite c |
AU2012311461B2 (en) | 2011-09-22 | 2017-07-06 | Janssen Pharmaceuticals, Inc. | Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV |
AR088568A1 (es) | 2011-10-28 | 2014-06-18 | Janssen Pharmaceuticals Inc | Proceso mejorado para preparar un compuesto intermedio del inhibidor macrociclico de la proteasa tmc 435 |
-
2016
- 2016-03-24 MA MA041812A patent/MA41812A/fr unknown
- 2016-03-25 US US15/559,910 patent/US20180093943A1/en not_active Abandoned
- 2016-03-25 JP JP2017550186A patent/JP2018517661A/ja active Pending
- 2016-03-25 EA EA201792114A patent/EA201792114A1/ru unknown
- 2016-03-25 MX MX2017012348A patent/MX2017012348A/es unknown
- 2016-03-25 BR BR112017019898A patent/BR112017019898A2/pt not_active Application Discontinuation
- 2016-03-25 CN CN201680018539.7A patent/CN107429270A/zh active Pending
- 2016-03-25 WO PCT/IB2016/051720 patent/WO2016157058A1/fr active Application Filing
- 2016-03-25 AU AU2016241924A patent/AU2016241924A1/en not_active Abandoned
- 2016-03-25 KR KR1020177026974A patent/KR20170131449A/ko unknown
- 2016-03-25 CA CA2976175A patent/CA2976175A1/fr not_active Abandoned
- 2016-03-25 EP EP16715347.7A patent/EP3274324A1/fr not_active Withdrawn
- 2016-03-25 SG SG11201707594SA patent/SG11201707594SA/en unknown
-
2017
- 2017-08-08 IL IL253899A patent/IL253899A0/en unknown
-
2018
- 2018-05-17 HK HK18106372.5A patent/HK1247246A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20170131449A (ko) | 2017-11-29 |
US20180093943A1 (en) | 2018-04-05 |
BR112017019898A2 (pt) | 2018-06-12 |
EP3274324A1 (fr) | 2018-01-31 |
CA2976175A1 (fr) | 2016-10-06 |
MX2017012348A (es) | 2017-12-14 |
AU2016241924A1 (en) | 2017-08-24 |
SG11201707594SA (en) | 2017-10-30 |
IL253899A0 (en) | 2017-10-31 |
EA201792114A1 (ru) | 2018-01-31 |
WO2016157058A1 (fr) | 2016-10-06 |
CN107429270A (zh) | 2017-12-01 |
JP2018517661A (ja) | 2018-07-05 |
HK1247246A1 (zh) | 2018-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44884A (fr) | Dispositifs et procédés de thrombectomie de l'artère carotide interne | |
IL271025A (en) | Multibiotic substances and methods of using them | |
SG11202010636VA (en) | Solid forms of an fgfr inhibitor and processes for preparing the same | |
MA46315A (fr) | Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine | |
MA43515A (fr) | Méthodes et compositions d'inhibition de l'interaction de la ménine avec les protéines mll | |
MA45688A (fr) | Compositions et procédés de potentialisation d'agents antimicrobiens | |
MA51306A (fr) | Compositions et procédés améliorés pour le traitement du déficit en ornithine transcarbamylase | |
SG10202100100UA (en) | Pd-l1-specific antibodies and methods of using the same | |
IL253999B (en) | History of tetrahydrothiazepine in cyclics used to treat neoplastic and/or infectious diseases | |
IL281015A (en) | Methods and preparations for plant modification | |
PL3296048T3 (pl) | Piła o zmniejszonym pyleniu i sposób jej użycia | |
IL266132B (en) | Pharmaceutical formulations and methods for their preparation | |
IL288830A (en) | Methods for purifying an antibody and its preparations | |
IL283850A (en) | Cannabis compounds and methods | |
MA42497A (fr) | Procédés et compositions pour la régulation sélective de l'expression protéique | |
MA46431A (fr) | Composés et procédés pour réduire l'expression de tau | |
EP3443105A4 (fr) | Plantes de cannabis améliorées et procédés pour les produire et l'utiliser | |
SG10201605869QA (en) | Methods For Purification Of A Virus Produced In Vitro And Clearance Assay For The Virus | |
MA40904A (fr) | Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie | |
MA42130A (fr) | Combinaisons d'opioïdes et de n-acyléthanolamines | |
KR102292781B9 (ko) | 폴리글리콜리드-폴리락티드 다중블록공중합체 수지 및 그 제조방법 | |
MA45272A (fr) | Produits issus de liquide amniotique et procédés d'utilisation | |
MA41812A (fr) | Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc | |
MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine | |
MA43764A (fr) | Inhibiteur monovalent de l'interaction hutnfr1 |